UBS Specialty Pharma Conference
Upcoming SlideShare
Loading in...5
×
 

UBS Specialty Pharma Conference

on

  • 939 views

 

Statistics

Views

Total Views
939
Views on SlideShare
939
Embed Views
0

Actions

Likes
0
Downloads
2
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    UBS Specialty Pharma Conference UBS Specialty Pharma Conference Presentation Transcript

    • Innovative Drug Delivery Device Solutions Ramin Mojdeh, Ph.D. Executive Vice President and Chief Operating OfficerUBS Specialty Pharma Conference May 2011
    • Cautionary Note Regarding Forward-Looking StatementsThis presentation contains forward looking statements under thesafe harbor provisions of the US securities laws. These forward-looking statements are based on management’s beliefs andassumptions and on information currently available to ourmanagement. Our management believes that these forward-looking statements are reasonable as and when made. Howeveryou should not place undue reliance on any such forward lookingstatements as these are subject to risks and uncertainties. Pleaserefer to our press release and our SEC filings for more informationregarding the use of forward looking statements. 2
    • Introducing UnilifeEmerging global leader in innovative drug delivery device solutionsEnable and enhance delivery of drugs by pharmaceutical customersRapidly expanding pipeline being driven by customer needsUnifill – world’s only prefilled platform with integrated safetyNASDAQ listed (UNIS) with state-of-the-art facility in York, PA 3
    • Attractive Market Trends and Opportunity$30B Injectable drug delivery device market in 2015, 12.3% CAGRLarge macromolecule composition of pharmaceutical pipelineSafety legislation and sharps managementDevices drive patient acceptance, preference and adherenceEmerging healthcare needs of aging global populationRising global healthcare standards creating strong market potentialImproved outcomes and economics with use of unit-dose and ready toadminister formatsTrend to patients self-administration of injectable drugsPatent cliff - 30 biologics with $51B sales expire by 2015 4
    • Strategic FocusInnovative device solutions for commercial drugs/biosimilars Integrated proprietary primary drug delivery devices with value-add featuresTarget and address emerging unmet needs for pipeline drugs Pharmaceutical collaborations – specialized devices for novel drugsTarget high-end of market for differentiated devices, high margins Strategic sourcing of components In-house manufacturing and final assembly 5
    • Customer-Driven Technology PipelineTechnology pipeline developed in partnership with customersDirectly responding to emerging customer needs including: Integrated primary drug delivery devices with value-add features and customization Advanced syringe systems with integrated safety and transfer mechanisms Dry drug reconstitution and delivery technologies Large-volume viscous drugs delivery technologies Targeted organ delivery devices Multi-chamber proprietary primary containers and delivery systems Reusable and disposable self administration device technologiesTechnology portfolio can be leveraged to develop customizeddevice concepts according to specific customer needs 6
    • Unifill – The Leading Edge of Our PortfolioWorld’s first and only prefilled syringes with integrated safetyNow in productionControlled retraction into barrelNeedle locked after use for convenient, compact disposal 7
    • Unifill as a Game Changer 2.5B Units Annually Primary drug delivery device with integrated safety Ancillary + safety needle Unifill Direct substitute for Platform current prefill and safetyStandard Current prefill syringes Prefill SafetySyringe Syringe Direct Substitute Powerful brand differentiation Ancillary Streamlines fill-finish + safety Device and packaging process Optimal protectionStandard Current Prefill SafetySyringe Syringe 8
    • Success in the Face of a Big ChallengeTechnology solves a technical challenge most thought impossibleSanofi invested $40MM for access rights to UnifillReady for initial shipment in July – well ahead of originalscheduleCurrent capacity of 60MM units, planned 150MM unit lineextension 9
    • New Paradigm in Drug-Device Development Clinical Development (phase I, II, III) Approval Sales Patient requirements Drugindustrialization requirements Customized delivery device Devices customized to specific requirements of drugs and target patients Collaboration with drug companies from clinical development through commercial sales Unique devices increasingly used to differentiate brands, optimize product lifecycles and enhance patient care 10
    • SummaryUnilife - emerging global leader in innovative drug delivery devicesInjectable drug delivery device market is attractive and growing fastInnovative, differentiated devices for pipeline drugs and biosimilarsDeveloping rich portfolio of technologies driven by customer needUnifill: the 1st and only prefill syringe system with integrated safetyThe new drug-device paradigm is to target pipeline drugs to developtotal system solutions for the pharmaceutical partnerLaunch with Unifill, then drive growth with successive introductionsof innovative, differentiated devices 11